Comparison of Routine IM Influenza Immunization and Administration by Jet-injector (Med-Jet H4™) in Healthy Young Adults (Med-Jet H4™)
Comparison of Routine IM Influenza Immunization and Administration by Jet-injector (Med-Jet MIT H4™ & Disposable Cartridge) in Healthy Young Adults
Sponsor: MEDICAL INTERNATIONAL TECHNOLOGIES (MIT CANADA) INC.
This PHASE4 trial investigates Needle Phobia and is currently completed. MEDICAL INTERNATIONAL TECHNOLOGIES (MIT CANADA) INC. leads this study, which shows 9 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Nov 2022 — Jul 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Nov 2022 [monthly]
Completed PHASE4
-
Oct 2019 — Jan 2021 [monthly]
Completed PHASE4
▶ Show 4 earlier versions
-
Sep 2018 — Oct 2019 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Jun 2018 — Sep 2018 [monthly]
Active Not Recruiting PHASE4
-
Dec 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE4
-
Jun 2017 — Dec 2017 [monthly]
Active Not Recruiting PHASE4
First recorded
May 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- MEDICAL INTERNATIONAL TECHNOLOGIES (MIT CANADA) INC.
- MedTeq
- brian.ward
For direct contact, visit the study record on ClinicalTrials.gov .